The biotech startup's treatment uses light to destroy target cells, offering patients a way to heal with minimal damage to healthy tissue.
Biotech startup Rakuten Medical is eyeing the U.S. market for its novel idea to conquer cancer — light illumination therapy. The treatment, based on photoimmunotherapy — a combination of drug administration and illumination with red light — has long been in development as part of its Alluminox platform.
Extract — continue reading at the source.
Related stories
Cars burned and shops looted as anti-immigration protests rock South Africa
As influenza cases rise, residents rush to get flu shots
Chile: Santiago flooding turns streets to rivers as Kast declares state of catastrophe
Winner of 2026 Nobel peace prize to be announced - Europe Live
Oil Prices Retreat After Trump Appears to Rule out Iran Strikes Before Midterms
Palantir’s Tom Watson says ‘mob rule’ must not dictate awarding of government contracts